Stockreport

GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates

GH Research PLC - Ordinary Shares  (GHRS) 
PDF Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and expected completio [Read more]